In psychopathology, the p-factor suggests the presence of a common factor driving various mental health disorders. A recent Translational Psychiatry study aimed to discover p-factor-related plasma ...

Role of Apparent Diffusion Coefficient Map-Based First- and High-Order Radiomic Features for the Discrimination of Sacral Chordomas and Chondrosarcomas With Overlapping Conventional Imaging Features ...

Background: The changes in the liver in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However it has remained difficult to ...

How early in the course of Alzheimer’s disease can a blood marker detect amyloid pathology, and which marker does it best? At this year’s Alzheimer’s Association International Conference, held from ...

Plasma circulating tumor DNA (ctDNA) analysis is routine for genotyping of advanced non–small-cell lung cancer (NSCLC); however, early response assessment using plasma ctDNA has yet to be well ...

The use of blood tests, particularly of p-tau217, in the diagnosis of Alzheimer’s disease has taken off in the last few years, with the number of tests being prescribed now doubling every four to six ...

Analysis of blood samples from patients treated with Aramchol in ARMOR (Ph3 MASH Study) provides new and important insights into the biochemical and physiological effects of the drug. The ...

COCHIN, KERALA, INDIA, June 20, 2025 /EINPresswire.com/ -- Agappe Diagnostics Ltd is poised to pioneer a transformative chapter in Alzheimer’s diagnostics by ...

This is the first study to demonstrate a consistent and profound elevation of plasma PTX3 levels in NASH patients whose diagnosis was based on results of liver biopsy, the gold standard for the ...